Our Company

Hememics Biotechnologies is transforming the future of diagnostics with breakthrough monolayer graphene technology. Our innovative, pocket-sized reader and advanced multiplexed-sensor chips deliver precise results for small-molecule and protein tests in just five minutes even in the toughest environments thanks to this technology’s resistance to dirt and contaminants.

​

Serving multi-billion-dollar markets, we collaborate with industry leaders in drug testing, agriculture, biodefense, and emergency diagnostics. Hememics is on a mission to be the "Intel Inside" of graphene-based sensor technology, empowering partners to create next-generation diagnostic solutions.

​

Our platform features cost-effective, polymer-based, disposable sensors, eliminating the need for expensive silicon fabrication in clean rooms. By combining speed, accuracy, affordability, and ease of use, Hememics is redefining what is possible in diagnostic testing—making advanced healthcare and biosecurity more accessible than ever.